“Lymphoma red flag”的搜索结果，显示 251-260 项，共有 9076 项
on-Hodgkin lymphoma, Hodgkin lymphoma, Cutaneous t-cell lymphoma, Lymphoma, Small lymphocytic lymphoma, B-cell lymphoma, Diffuse large b-cell lymphoma ...
A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients.
The purpose of this study is to create a long-term, prospective database of cutaneous lymphoma that will lead to a better understanding of the biological ...
... lymphoma. Ibrutinib may stop the growth of cancer cells by blocking some of ... Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or ...
... lymphoma. Sacituzumab Tirumotecan (MK-2870) In Combination With Pembrolizumab Versus Pembrolizumab Alone In Metastatic Non-small Cell Lung Cancer (NSCLC) ...
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...
... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a ...
A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this trial is to ...
Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。